Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure

There were no differences in clinical outcomes of platinum-based chemotherapy according to the T790M status of NSCLC patients.